Choosing IXICO means partnering with a company entirely focused on neuroscience, with deep therapeutic and neuroimaging expertise across multiple neurodegenerative disease indications
Deep knowledge and extensive experience in optimising neuroimaging biomarkers and imaging techniques for multi-centre trials.
Commitment to advancing imaging methodologies through ongoing research and development.
Robust quality management processes compatible with national and international regulatory frameworks to deliver regulatory-compliant endpoints.
Strong ties with academic and industry leaders, fostering a collaborative approach to tackling the challenges of neurological disease research.
Patient-centric site management that considers the specific access and comfort needs of neurological disease patients.